Skip to content
Megan A. Baumgart, M.D.

Megan A. Baumgart, M.D.


4.9 out of 5 stars
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients


About Me

I chose the field of oncology because I want to help patients through one of the most difficult experiences a person can have.

Cancer treatment requires a team approach involving the patient, medical oncologist, nurses and support staff, as well as other medical teams such as radiation oncolo...
I chose the field of oncology because I want to help patients through one of the most difficult experiences a person can have.

Cancer treatment requires a team approach involving the patient, medical oncologist, nurses and support staff, as well as other medical teams such as radiation oncology and surgery who are often part of a patient's care. I work with patients to help them understand the overall treatment plan – especially the role of chemotherapy in the treatment of their disease – and support them throughout the course of treatment.

I am optimistic about the future of cancer treatment and want to work towards finding new and better treatment strategies for lung and head and neck cancers through the development of our clinical trials program. We currently have several clinical trials evaluating the role of immunotherapy for the treatment of metastatic head and neck cancers open for enrollment, as well as other clinical trials focused on answering important questions regarding the management of these diseases.

Conditions I Treat

- Small cell lung cancer
- Non-small cell lung cancer
- Head and neck cancers
- Thyroid cancer

Certified Specialties

Internal Medicine - American Board of Internal Medicine

Medical Oncology - American Board of Internal Medicine

Faculty Appointments

Associate Professor - Department of Medicine, Hematology/Oncology (SMD)


Residency & Fellowship

Fellowship, Medical Oncology, Yale New Haven Hospital. 2011 - 2014

Residency, Internal Medicine, Rhode Island Hospital. 2008 - 2010

Internship, Internal Medicine, Rhode Island Hospital. 2007 - 2008


MD | Albany Medical College. 2007


Early Career Women Faculty Leadership Development Seminar. 2019

Annual Award for Outstanding Oncology Research. 2014

Albany Medical College- Distinction in Biomedical Ethics. 2007


Clinical Trials

A Randomized Phase III Trial of Chemo-Immunotherapy vs Immunotherapy Alone for the Vulnerable Older Adult With Advanced Non-Small Cell Lung Cancer: The ACHIEVE Study

Lead Researcher: Megan A Baumgart

This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help...

A Phase II Study of AMG 510 in Participants With Previously Treated Stage IV or Recurrent KRAS G12C Mutated Non-Squamous Non-Small Cell Lung Cancer (ECOG-ACRIN LUNG-MAP SUB-STUDY)

Lead Researcher: Megan A Baumgart

This phase II Lung-MAP treatment trial studies the effect of AMG 510 in treating non-squamous non-small cell lung cancer that is stage IV or has come back (recurrent) and has a specific mutation in the KRAS gene, known as KRAS G12C. Mutations in this...

A pilot study of pembrolizumab and single agent chemotherapy as first line treatment for patients with locally advanced or metastatic non-small cell lung cancer with Eastern Cooperative Oncology Group (ECOG) performance status of 2

Lead Researcher: Megan A Baumgart

The purpose of this study is to understand if treatment with one chemotherapy medication combined with immune therapy (pembrolizumab) is tolerable and effective for patients with lung cancer and performance status of 2 (PS2), which means you have lim...

Nivolumab Versus Observation in Treating Patients With Locally Advanced, Intermediate Risk HPV-Positive Oropharyngeal Cancer (EA3161)

Lead Researcher: Megan A Baumgart

This phase III trials studies whether maintenance immunotherapy (nivolumab) following definitive treatment with radiation and chemotherapy (cisplatin) result in significant improvement in overall survival (time being alive) and progression-free survi...

LUNGMAP: A Master Protocol To Evaluate Biomarker-Driven Therapies And Immunotherapies In Previously-Treated Non-Small Cell Lung Cancer (Lung-Map Screening Study)

Lead Researcher: Megan A Baumgart

This screening and multi-sub-study randomized phase II/III trial will establish a method for genomic screening of similar large cancer populations followed by assigning and accruing simultaneously to a multi-sub-study hybrid Master Protocol (Lung-MAP...


Journal Articles

PUB031 PRIMAL: A Phase 1b Study of PEGPH20 plus Docetaxel in Patients with Previously Treated Hyaluronan (HA)-High Advanced NSCLC

Baumgart, M.; Bazhenova, L.; Haggstrom, D.; Baranda, J.; Belani, C.

Journal of Thoracic Oncology. 2017; 12(1): S1465.

Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.

Abu-Khalaf MM, Baumgart MA, Gettinger SN, Doddamane I, Tuck DP, Hou S, Chen N, Sullivan C, Lezon-Geyda K, Zelterman D, Hatzis C, Deshpande H, Digiovanna MP, Azodi M, Schwartz PE, Harris LN

Cancer.. 2015 June 1121 (11):1817-26. Epub 02/03/2015.

New molecular targets on the horizon in non-small cell lung cancer

Baumgart, M.

American Journal of Hematology and Oncology. 2015; 11(6): 10-13.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.


During this visit, did this provider spend enough time with you?

4.9 stars

During this visit, did this provider show respect for what you had to say?

5.0 stars

During this visit, did this provider give you easy to understand information about these health questions or concerns?

5.0 stars

During this visit, did this provider listen carefully to you?

5.0 stars

During this visit, did this provider explain things in a way that was easy to understand?

4.9 stars

Patient Comments

5.0 stars

Very professional and took the time to make sure I understood all the answers

Apr 19, 2024

5.0 stars

My wife and I are thrilled to have Dr. Baumgart handling my cancer treatments. She is extremely considerate, personable and compassionate.

Nov 17, 2023

5.0 stars

During and following the cancer and treatments, the team has been very helpful and truthful.

Nov 06, 2023

5.0 stars

Dr. Baumgart is wonderful, we thank her every day for my excellent care. She is professional, caring, & thoughtful, we are very thankful for her excellent care.

Oct 19, 2023

5.0 stars

Dr. Megan Baumgart Is a wonderful doctor. She has helped me tremendously with my cancer care.

Sep 18, 2023

5.0 stars

Dr. Baumgart has always been considerate and tolerant of all our questions. She is thorough in her explanations and has always spent a more than reasonable amount of time with us. We are very impressed with her knowledge and demeanor.

Jul 08, 2023

5.0 stars

Dr. Baumgart is an excellent and very thoughtful and caring Physician as are all of her staff .

Jun 03, 2023

5.0 stars

She is very patient and explains everything in a manner that I can fully understand.

Apr 23, 2023

Dr. Baumgart was thorough and detailed in her explanations of my condition and planned treatment. My wife and I are extremely grateful for the time she spent with us and her compassionate manner.

Apr 07, 2023

5.0 stars

Dr. Baumgart is amazing. I feel like I am in the best hands possible. I trust him completely.

Mar 24, 2023


Dr. Baumgart, Dr. Zhao and Karen Mietus, RN were all exceptionally considerate, compassionate and knowledgeable. I couldn't be happier with my new thoracic oncology team.

Mar 24, 2023


I met Dr. Baumgart when my father was diagnosed with lung cancer. When I was diagnosed I immediately knew who I wanted to care for me.

Mar 20, 2023

I love my Drs and all of their staff . I am blessed to have been referred to the U of R as soon as I was diagnosed.

Feb 22, 2023


Dr. Baumgart always includes me in any discussion of further treatments.

Feb 16, 2023


She was absolutely phenomenal! Patient and kind!

Oct 16, 2022


Dr. Baumgart and her staff have been treating me for 7 yrs. They have been the utmost professionals I have recommend them to others. I love this group.

Oct 14, 2022


Provider tells it like it is. No punches.

Oct 10, 2022


Could not have a better Provider.

Aug 01, 2022


Dr. Baumgart is a wonderful person and has treated me to my highest expectation.

Jul 08, 2022



May 25, 2022


Megan, Allison and nurse Karen are the best..

May 07, 2022


It is comforting to know that all on the team are concerned and treat me with respect and professionalism.

Apr 21, 2022


Outstanding care.

Mar 20, 2022


I would hope my friends do not need an oncologist but if they do 100% I would recommend them!!

Mar 17, 2022


Dr. Baumgart is an excellent physician.

Feb 06, 2022